NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024
Mary B. Daly(Fox Chase Cancer Center), Susan Darlow(National Comprehensive Cancer Network), Matthew B. Yurgelun(Dana-Farber Brigham Cancer Center), Gwen Reiser(University of California San Diego), Marie Wood(University of Colorado Cancer Center), Zahraa Al‐Hilli(Cleveland Clinic), Christine Laronga(University of California, San Francisco), Banu Arun(The University of Texas MD Anderson Cancer Center), Dominique Rash(UC San Diego Health System), Andrea R. Hagemann, Tuya Pal(Breast Cancer Research Foundation), Carolyn S. Menendez(Memorial Sloan Kettering Cancer Center), Katia Khoury(University of Colorado Cancer Center), Heather H. Cheng(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Kristen M. Shannon(Massachusetts General Hospital), John C. Mansour(Southwestern Medical Center), Leigha Senter-Jamieson(City Of Hope National Medical Center), Wendy Kohlmann(University of Utah), Kara N. Maxwell(University of Pennsylvania), Susan M. Domchek(University of Pennsylvania), Allison W. Kurian(Stanford University), Nawal Kassem(Indiana University Melvin and Bren Simon Comprehensive Cancer Center), Sofía D. Merajver(University of Michigan), Myra Wick, Saundra S. Buys(University of Utah), Veda N. Giri(Yale Cancer Center), Beth Y. Karlan(University of Colorado Cancer Center), Mollie L. Hutton(Roswell Park Comprehensive Cancer Center), Ashley Hendrix(St. Jude Children's Research Hospital), Kala Visvanathan(St. Elizabeth's Hospital), Michael Goggins(Johns Hopkins University), Jane Churpek(University of Wisconsin Carbone Cancer Center), Kevin McDonnell(City Of Hope National Medical Center), Jeanna Welborn(UC Davis Comprehensive Cancer Center), Susan Friedman(Facing Our Risk of Cancer Empowered), Mary A. Dwyer(National Comprehensive Cancer Network), Kenneth Offit(Memorial Sloan Kettering Cancer Center), Seema Khan(University of Colorado Cancer Center), Julie Mak(University of Michigan)
Cited by 284
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k